PubMed:33407777 / 0-188 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"4","span":{"begin":109,"end":117},"obj":"Species"},{"id":"5","span":{"begin":123,"end":158},"obj":"Disease"},{"id":"6","span":{"begin":166,"end":174},"obj":"Disease"},{"id":"7","span":{"begin":176,"end":184},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"tao:has_database_id","subj":"4","obj":"Tax:9606"},{"id":"A5","pred":"tao:has_database_id","subj":"5","obj":"MESH:D012128"},{"id":"A6","pred":"tao:has_database_id","subj":"6","obj":"MESH:C000657245"},{"id":"A7","pred":"tao:has_database_id","subj":"7","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":129,"end":149},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":186},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A"}